194 completed. 194 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 194 | Completed 194 |
Follow Glaucoma: new trials by email Literature Review of Glaucoma trials Research Report on Glaucoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of Visual Field Assessments Between Three Perimeters Visual field assessment - Glaucoma | Phase 4 | Completed | Gainesville Eye Associates | 54 | 2024-11-18 | 2026-04-30 |
| Effect of Netarsudil vs Brimonidine in NTG Patients on Latanoprost Netarsudil, Brimonidine - Normal Tension Glaucoma | Phase 4 | Completed | Westlake Eye Specialists | 100 | 2024-06-13 | 2025-10-22 |
| MEXIDOL® Sequential Therapy of Patients With Primary Open-angle Glaucoma (POAG) Mexidol - Primary Open-Angle Glaucoma (POAG) | Phase 4 | Completed | Pharmasoft | 80 | 2023-09-15 | 2025-12-12 |
| Dorzolamide+Timolol Multidose Preservative-free vs Dorzolamida+Timolol BAK Preserved Efficacy and Safety Dorzolamide / Timolol Ophthalmic Solution, dorzolamide/timolol - Glaucoma, Open-Angle, Ocular Hypertension | Phase 4 | Completed | Laboratorios Poen | 84 | 2023-03-07 | 2024-11-06 |
| Rocklatan® Evaluation Netarsudil 0.02%/latanoprost 0.005% fixed dose combination ophthalmic solution - Glaucoma | Phase 4 | Completed | Aerie Pharmaceuticals | 136 | 2022-03-28 | 2024-04-03 |
| Comparison of Efficacy and Ocular Surface Assessment Between BRIDIN-plus and Combigan in Glaucoma or Ocular Hypertensive BRIDIN-plus Eye drops, Combigan Eye drops - Glaucoma, Ocular Hypertensive | Phase 4 | Completed | CHA University | 60 | 2021-10-08 | 2025-03-26 |
| To Evaluate the Effect of Ginkgo Biloba Extract on Optic Nerve Head Perfusion Examined Using OCTA Ginkgo biloba extract - Glaucoma | Phase 4 | Completed | Nova Scotia Health Authority | 15 | 2021-05-01 | 2024-08-21 |
| Aqueous Humor Dynamic Components That Determine Intraocular Pressure Variance Timolol 0.5% ophthalmic solution, Latanoprost 0.005% Ophthalmic Solution - Glaucoma, OHT - Ocular Hypertension | Phase 4 | Completed | Ohio State University | 59 | 2020-11-23 | 2026-03-04 |
| The Effect of Topical Brimonidine on the Ocular Hemodynamics in Patients of POAG Using OCTA Brimonidine tartrate 0.2% ophthalmic solution - Glaucoma, Primary Open Angle, Ocular Blood Flow | Phase 4 | Completed | Fayoum University | 41 | 2020-05-01 | 2022-07-26 |
| Investigate, Following Cataract Surgery With IOL in Conjunction With Intracanalicular Dexamethasone Insert Intracanalicular Dexamethasone, 0.4 mg insert - Glaucoma, Primary Open Angle, Cataract | Phase 4 | Completed | Wolstan and Goldberg Eye Associates | 40 | 2020-02-10 | 2022-08-22 |
| Nailfold Capillary Blood Flow With Latanoprost Bunod Latanoprost 0.005%, Latanoprost bunod 0.024%, Normal saline 0.9% - Glaucoma, Open-Angle | Phase 4 | Completed | Icahn School of Medicine at Mount Sinai | 47 | 2019-08-15 | 2021-09-29 |
| Comparison of Efficacy and Ocular Surface Disease Assessment Between Monoprost and BAK-preserved Latanoprost Monoprost, Xalatan - Glaucoma, Ocular Hypertension | Phase 4 | Completed | CHA University | 57 | 2019-04-30 | 2021-02-08 |
| Tafluprost Preservative Free Switch Study preservative free tafluprost 0.0015% - Glaucoma, Primary Open Angle Glaucoma | Phase 4 | Completed | Tun Hussein Onn National Eye Hospital | 28 | 2019-02-01 | 2020-12-04 |
| Study of Rhopressa® for the Reduction of Elevated Intraocular Pressure in Patients With Glaucoma or Ocular Hypertension in a Real-world Setting Netarsudil Ophthalmic Solution 0.02% - Glaucoma, Open-Angle, Ocular Hypertension | Phase 4 | Completed | Aerie Pharmaceuticals | 261 | 2018-12-27 | 2020-09-29 |
| XEN-45 Gel Stent Versus Trabeculectomy in Glaucoma: Gold-Standard Pathway Study (GPS) XEN-45 Gel Stent, Trabeculectomy - Glaucoma | Phase 4 | Completed | Allergan | 158 | 2018-10-01 | 2022-07-21 |
| Effect of Topical Dexmedetomidine on Intraocular Pressure Dexmedetomidine, Balanced salt solution - Glaucoma, Intraocular Pressure | Phase 4 | Completed | Beirut Eye Specialist Hospital | 49 | 2017-12-01 | 2018-10-03 |
| Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma brinzolamide 1%/brimonidine 0.2% fixed combination, Placebo, travoprost 0.004% ophthalmic solution - Glaucoma | Phase 4 | Completed | Novartis Pharmaceuticals | 1 | 2017-09-21 | 2019-02-25 |
| Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography Study Timolol Maleate, Brimonidine Tartrate - Glaucoma; Drugs, Normal Tension Glaucoma | Phase 4 | Completed | Wills Eye | 35 | 2017-07-10 | 2020-12-31 |
| The Effect of Antihypertensive Medication Timing on Morbidity and Mortality Use of blood pressure lowering medication at bedtime, Use of blood pressure lowering medication in the morning - Hypertension | Phase 4 | Completed | University of Alberta | 3357 | 2017-03-31 | 2024-08-27 |
| Efficacy and Tolerability of an Innovative Formulation of BAK-free Latanoprost Latanoprost Ophthalmic Product - Primary Open-angle Glaucoma | Phase 4 | Completed | Laboratorios Poen | 103 | 2017-01-06 | 2017-11-08 |
Showing 20 of 194. Sign in to see all of them.
Glaucoma, Open-Angle (99) · Ocular Hypertension (98) · Eye Diseases (8) · Low Tension Glaucoma (5) · Cataract (3) · Dry Eye Syndromes (2) · Glaucoma, Neovascular (2) · Hypertension (2) · Patient Compliance (2) · Cardiovascular Diseases (1) · Dementia (1) · Diabetic Retinopathy (1) · Exfoliation Syndrome (1) · Fibrosis (1)
Eye Diseases (186) · Ocular Hypertension (96) · Optic Nerve Diseases (6) · Cardiovascular Diseases (5) · Vascular Diseases (5) · Lens Diseases (3) · Nervous System Diseases (3) · Retinal Diseases (3) · Behavior (2) · Cranial Nerve Diseases (2) · Health Behavior (2) · Lacrimal Apparatus Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2)
Latanoprost (46) · Travoprost (45) · Timolol (43) · Bimatoprost (33) · Ophthalmic Solutions (27) · brinzolamide (25) · Brimonidine Tartrate (24) · dorzolamide (21) · dorzolamide-timolol combination (18) · Azarga (11) · Duotrav (10) · tafluprost (9) · Brimonidine Tartrate, Timolol Maleate Drug Combination (8) · Ganfort (6) · Lubricant Eye Drops (6)
Alcon Research (44) · Allergan (25) · Aristotle University Of Thessaloniki (13) · Glaukos Corporation (11) · Innovative Medical (5) · Pharmaceutical Research Network (5) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (4) · Wills Eye (4) · Aerie Pharmaceuticals (2) · Bp Consulting, Inc (2) · CHA University (2) · Indiana University (2) · Laboratoires Thea (2) · Laboratorios Poen (2) · Maisonneuve-Rosemont Hospital (2)
United States (59) · Canada (18) · Italy (15) · Germany (13) · Greece (13) · Armenia (9) · Spain (9) · France (7) · Switzerland (7) · United Kingdom (7) · Austria (6) · South Korea (6) · China (5) · Belgium (4) · Poland (4)
William C. Stewart, MD (6) · Anastasios G Konstas, MD, PhD (5) · Robert Noecker, MD (5) · Severine Durier, Pharm.D (3) · Abayomi Ogundele, PharmD (2) · Anastasios GP Konstas, MD, PhD (2) · Danyel Carr, MS (2) · Elizabeth D. Sharpe, MD (2) · Jeff Wells, PharmD, MBA (2) · John Liu, PhD (2) · Lilit A Voskanyan, MD, PhD (2) · Lilit Voskanyan, MD, PhD (2)
PMID 36912740, PMID 19476406, PMID 11589866, PMID 12614754, PMID 14509472, PMID 14736774, PMID 14996520, PMID 16249960, PMID 16303952, PMID 17102003, PMID 17191187, PMID 17415690, PMID 17686450, PMID 18173426, PMID 18402717, PMID 18826749, PMID 19157559, PMID 19668762, PMID 19825835, PMID 20181282, PMID 20505839, PMID 20553122, PMID 20668720, PMID 21048504, PMID 21773673, PMID 21960068, PMID 22205835, PMID 22458918, PMID 22918671, PMID 23475405, PMID 23681371, PMID 24006861, PMID 24452726, PMID 24855336, PMID 25432143, PMID 25519810, PMID 25982212, PMID 26563363, PMID 27162226, PMID 27293875, PMID 27913991, PMID 28034308, PMID 28239491, PMID 28454526, PMID 28617732, PMID 29226268, PMID 29267575, PMID 29477688, PMID 30328725, PMID 30758653
R01EY022124 (2), 2009 (1), 2015 (1)